WJOG13219G: Triplet versus doublet in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer: A multi-institutional real-world data analysis (BRACELET study).

Authors

null

Keitaro Shimozaki

Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo, Japan

Keitaro Shimozaki , Kenro Hirata , Tarou Sato , Maho Nakamura , Kyoko Kato , Hidekazu Hirano , Yosuke Kumekawa , Kaori Hino , Kentaro Kawakami , Yosuke Kito , Toshihiko Matsumoto , Takeshi Kawakami , Masato Komoda , Kengo Nagashima , Yasunori Sato , Kentaro Yamazaki , Shuichi Hironaka , Yasuo Hamamoto , Hiromasa Takaishi , Kei Muro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

DOI

10.1200/JCO.2022.40.4_suppl.037

Abstract #

37

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Andrew Trunk

First Author: Vanessa Wong

Poster

2020 ASCO Virtual Scientific Program

Real-world outcomes of patients with BRAF-mutated mCRC treated in the United States.

Real-world outcomes of patients with BRAF-mutated mCRC treated in the United States.

First Author: Matthew Braithwaite